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Background
Guidelines recommend that patients presenting with
acute severe asthma with life-threatening features
receive the necessary high doses of b2-agonists via the
nebulized route.The SideStream Plus (SS+; Philips
Respironics) is a breath-enhanced nebulizer designed to
maximize respirable output, while minimizing treatment
time [1]. Prior to the introduction of a new version of
nebulizer, various in vitro assessments, including inter
and intra batch variability, are performed using a limited
number of devices. We present results of an analysis of
inter and intra batch variability of SS+ nebulizers.
Method
SS+ nebulizers (3 batches; n=30 per batch) were assessed
in terms of 5 experimental parameters; nebulization time,
residual volume, particle size distribution (mass median
diameter (MMD), fine particle fraction (FPF)), and emitted
dose. Each batch was provided with a driving flow from a
different Porta-neb compressor (Philips Respironics).
Measurement of particle size distribution was achieved
using a laser diffractor (Malvern Spraytec) with an extrac-
tion flow of 15 l/min. Each nebulizer was weighed and
filled with 2.5 ml salbutamol sulphate (albuterol sulfate)
solution (1 mg/ml). To assess nebulization duration the
nebulizers were run continuously until ‘end of treatment’,
defined as when the obscuration level of the sample in the
laser diffractor fell below 5% for 5 s. At this point the SS+
were re-weighed to calculate residual volume. The dose
delivered to a filter placed between the laser diffractor and
extraction air flow was quantified using high performance
liquid chromatography. The coefficient of variation (CV)
for each experimental parameter was calculated for each
batch.
Results
Results are shown in Table1.
Conclusion
The intra batch coefficient of variation indicates that varia-
bility in each of the 5 experimental parameters did not dif-
fer substantially across the 3 batches tested. The close
similarity between mean values for each of the experimen-
tal parameters indicates that inter batch variability was
low. Taken together, these results suggest that different
batches of SS+ nebulizers should perform similarly in
terms of nebulization time, particle size distribution, and
emitted dose.
Respironics Respiratory Drug Delivery (UK) Ltd, Philips Home Healthcare
Solutions, UK
Table 1
Batch A CV (%) Batch A mean Batch B CV (%) Batch B mean Batch C CV (%) Batch C mean
Nebulization time (s) 13.1 274 9.3 258 9.6 270
Residual volume (mg solution) 6.6 1035 8.1 1100 9.9 1086
MMD (µm) 2.9 3.8 3.1 3.9 3.9 3.8
FPF (%<5 µm) 2.1 63.2 2.3 62.6 3.0 63.4
Emitted dose (µg salbutamol) 6.9 1127 9.2 1125 8.8 1101
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